Skip to main content
SpringerLink
Log in

The Role of Radiation Therapy in Malignant Lymphomas, Including Hodgkin’s Disease

  • Chapter
Lymphomas 1

Part of the book series: Cancer Treatment and Research ((CTAR,volume 4))

Abstract

The two decades spanning 1960 to 1980 have been witness to a remarkable expansion in knowledge concerning the nature, management, and prognosis of the malignant lymphomas including Hodgkin’s disease. This rapid gain in understanding, which is reflected in the outstanding therapeutic achievements of today, owes much to the painstaking investigation of several generations of radiation oncologists. Their efforts, often thwarted by primitive technologies, limited by patient referral patterns, and oftentimes opposed by a hostile medical opinion which deemed these disease fatal by definition, passed through many of the vicissitudes — the blind alleys, the frustating sidetracks — that many great scientific endeavors have had to negotiate. Finally, in the mid 1960s, the modern conceptions emerged. Before presenting these fundamental principles a brief journey through the annals of history will be undertaken to outline some of the milestones along the road to the present position.

Supported in part by the Clinical Research Center Grant, CA-11053. we acknowledge our gratitude to Miss Laurie Quinn for typing manuscript.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pusey WA: Cases of sarcoma and of Hodgkin’s disease treated by exposure to X-rays. J Am Med Assoc 38:166–169, 1902.

    Google Scholar 

  2. Gilbert R: Radiotherapy in Hodgkin’s disease (malignant granulomatosis): anatomic and clinical foundations, governing principles, results. Am J Roentgenol 41:198–241, 1939.

    Google Scholar 

  3. Buschke F: Radiation therapy: the past, the present, the future. Am J Roentgenol 108:236–246, 1970.

    CAS  Google Scholar 

  4. Bowing HH: The value of radium and x-ray therapy in Hodgkin’s disease. J Radiol 2:20–24, 1921.

    Google Scholar 

  5. Reed DM: On the pathological changes in Hodgkin’s disease, with especial reference to its relation to tuberculosis. Johns Hopkins Hosp Rep 10:133–196, 1902.

    Google Scholar 

  6. Rappaport H, Winter WJ, Hicks EB: Follicular lymphoma. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9:821–972, 1956.

    Article  Google Scholar 

  7. Easson ED, Russell MH: The cure of Hodgkin’s disease. BMJ 1:1704–1707, 1963.

    Article  PubMed  CAS  Google Scholar 

  8. Jackson H: Classification and prognosis of Hodgkin’s disease and allied disorders. Surg Gynecol Obstet 64:465–467, 1937.

    Google Scholar 

  9. Leucutia T: Irradiation in lymphosarcoma, Hodgkin’s disease and leukemia. Am J Med Sci 188:612–623, 1934.

    Google Scholar 

  10. Meraer TB, Stenstrom KW: Roentgen therapy in Hodgkin’s disease. J Radiol 48:355–368, 1947.

    Google Scholar 

  11. Peters MV: A study of survivals in Hodgkin’s disease treated radiologically. Am J Roentgenol 63:299–311, 1950.

    Google Scholar 

  12. Peters MV, Middlemiss KCH: A study of Hodgkin’s disease treated by irradiation. Am J Roentgenol 79:114–121, 1958.

    CAS  Google Scholar 

  13. Kaplan HS: The radical radiotherapy of regionally localized Hodgkin’s disease. Radiology 78:553–561, 1962.

    PubMed  CAS  Google Scholar 

  14. Kaplan HS, Rosenberg SA: Extended-field radical radiotherapy in advanced Hodgkin’s disease: short-term results of 2 randomized clinical trials. Cancer Res 26:1268–1276, 1966.

    PubMed  CAS  Google Scholar 

  15. Johnson RE, Cook PL: Hodgkin’s disease: negative lymphogram in guiding radiotherapy. Am J Roentgenol 102:883–890, 1968.

    CAS  Google Scholar 

  16. Prosnitz LR, Hellman S, von Essen C, Kligerman MM: The clinical course of Hodgkin’s disease and other malignant lymphomas treated with radical radiation therapy. Am J Roentgenol 105:628–668, 1969.

    Google Scholar 

  17. Rubin P, Keys H, Mayer E, Antmann R: Nodal recurrences following radical radiation therapy in Hodgkin’s disease. Am J Roentgenol 120:536–548, 1974.

    CAS  Google Scholar 

  18. Kaplan HS: On the natural history, treatment and prognosis of Hodgkin’s disease. The Harvey Lectures, series 64:215–259, 1968-1969.

    Google Scholar 

  19. Glatstein E, Guernsey JM, Rosenberg SA, Kaplan HS: The value of laparotomy and splenectomy in the staging of Hodgkin’s disease. Cancer 24:709–718, 1969.

    Article  PubMed  CAS  Google Scholar 

  20. Kaplan HS, Dorfman RF, Nelson TS: Staging laparotomy and splenectomy in Hodgkin’s disease: analysis of indications and patterns of involvement in 285 consecutive, unselected patients. Natl Cancer Inst Monogr 36:291–301, 1973.

    PubMed  CAS  Google Scholar 

  21. Peters MV: The evolution of the radiotherapeutic concept in Hodgkin’s disease. Ser Haematol 6:117–138, 1973.

    PubMed  CAS  Google Scholar 

  22. Piro AJ, Hellman S: Laparotomy alters treatment in Hodgkin’s disease. Natl Cancer Inst Monogr 36:307–311, 1973.

    PubMed  CAS  Google Scholar 

  23. Andrews JR: The radiobiology of human radiotherapy. Baltimore: University Park Press, 1978.

    Google Scholar 

  24. Fletcher GH: Textbook of radiotherapy. Philadelphia: Lea & Febiger, 1980, pp 180–219.

    Google Scholar 

  25. Kaplan HS: Evidence for a tumoricidal dose in the radiotherapy of Hodgkin’s disease. Cancer Res 26:1221–1224, 1966.

    PubMed  CAS  Google Scholar 

  26. Friedman M, Pearlman AN, Turgeon L: Hodgkin’s disease. Tumor lethal dose and iso-effect recovery curve. Am J Roentgenol 99:843–850, 1967.

    CAS  Google Scholar 

  27. Fletcher GH, Shukovsky LJ: The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol 56:383–400, 1975.

    PubMed  CAS  Google Scholar 

  28. Bush RS, Gospadarowicz M, Sturgeon J, Alison R: Radiation therapy of localized non-Hodgkin’s lymphoma. Cancer Treat Rep 61:1129–1136.

    Google Scholar 

  29. Steel GG, Peckham MJ: Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5:85–91, 1979.

    PubMed  CAS  Google Scholar 

  30. Oates JA, Wilkinson GR: Principles of drug therapy. In: Harrison’s principles of internal medicine, Isselbacher KJ, Adams RD, Braumwald E, Petersdorf RG, Wilson JD, eds. New York: McGraw-Hill, 1980, p 382.

    Google Scholar 

  31. Rubin P, Cooper R, Phillips TL: Radiation biology and radiation pathology syllabus (set R.T. 1: radiation oncology). Chicago: American College of Radiology, 1975.

    Google Scholar 

  32. Kaplan HS, Stewart JR: Complications of intensive megavoltage radiotherapy for Hodgkin’s disease. Natl Cancer Inst Monogr 36:439–444, 1973.

    PubMed  CAS  Google Scholar 

  33. Rubin P: Statement of the clinical oncologic problem. In: Clinical oncology for medical students and physicians. A multidisciplinary approach, Rubin P, Bakemeier RF, eds; Rochester, N. Y.: American Cancer Society, 1978, pp 1–10.

    Google Scholar 

  34. Spittle MF, Harmer CL, Cassady Jr, Kaplan HS: Analysis of primary relapses after radiotherapy in Hodgkin’s disease. Natl Cancer Inst Monogr 36:497–508, 1973.

    PubMed  CAS  Google Scholar 

  35. Kaplan HS, Rosenberg SA: Current status of clinical trials: Stanford experience, 1962–72. Natl Cancer Inst Monogr 36:363–371, 1973.

    PubMed  CAS  Google Scholar 

  36. Gamble JF, Fuller LM, Martin RG, Sullivan MP, Jing B-S, Butler JJ, Shullenberger CC: Influence of staging celiotomy in localized presentations of Hodgkin’s disease. Cancer 35:817–825, 1975.

    Article  PubMed  CAS  Google Scholar 

  37. Sweet DL, Kinnealey A, Ultmann JE: Hodgkin’s disease: problems of staging. Cancer 42:957–970, 1978.

    Article  PubMed  Google Scholar 

  38. Kaplan HS, Bissinger PA: Survival and relapse rates in Hodgkin’s disease: Stanford experience, 1961–71. Natl Cancer Inst Monogr 36:487–496, 1973.

    PubMed  CAS  Google Scholar 

  39. Glatstein E: Radiotherapy in Hodgkin’s disease. Past achievements and future progress. Cancer 39:837–841, 1977.

    Article  PubMed  CAS  Google Scholar 

  40. Peckham MJ, Ford HT, McElwain TJ, Harmer CL, Atkinson K, Austin DE: The results of radiotherapy for Hodgkin’s disease. Br J Cancer 32:391–400, 1975.

    Article  PubMed  CAS  Google Scholar 

  41. Weller SA, Glatstein E, Castellino RA, Kaplan HS, Rosenberg SA: Initial relapse in previously treated Hodgkin’s disease — II. Retrograde transdiaphragmatic extension. Int J Radiat Oncol Biol Phys 2:863–872, 1977.

    Article  PubMed  CAS  Google Scholar 

  42. Chabner BA, Johnson RE, Young RE, Canellos GP, Hubbard SP, Johnson SK, DeVita VT: Sequential nonsurgical and surgical staging of non-Hodkin’s lymphoma. Ann Intern Med 85:149–154, 1976.

    PubMed  CAS  Google Scholar 

  43. Goffinet DR, Warnke R, Dunnick NR, Castellino R, Glatstein E, Nelson TS, Dorfman RF, Rosenberg SA, Kaplan HS: Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin’s lymphomas. Cancer Treat Rep 61:981–992, 1977.

    PubMed  CAS  Google Scholar 

  44. Bonadonna G, Lattuada A, Banfi A: Recent trends in the treatment of non-Hodgkin’s lymphomas. Eur J Cancer 12:661–673, 1976.

    Article  PubMed  CAS  Google Scholar 

  45. Sweet DL, Golomb HM: The treatment of histiocytic lymphoma. Semin Oncol 7:302–309, 1980.

    PubMed  CAS  Google Scholar 

  46. Peters MV, Brown TC, Rideout DF: Prognostic influences and radiation therapy according to pattern of disease. JAMA 223:53–59, 1973.

    Article  PubMed  CAS  Google Scholar 

  47. Fuller LM, Madoc-Jones H, Hagemeister FB, Rodgers RW, North LB, Butler JJ, Martin RG, Gamble JR, Schullenberger CC: Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin’s disease patients: significance of mediastinal and non-mediastinal presentations. Int J Radiat Oncol Biol Phys 6:499–808, 1980.

    Google Scholar 

  48. Hoppe RT, Coleman CN, Kaplan HS, Rosenberg SA: Hodgkin’s disease, pathologic stage I-II. The prognostic importance of initial sites of disease and extent of mediastinal involvement. Proc Am Soc Clin Oncol 21:471, 1980.

    Google Scholar 

  49. Seydel HG, Bloedorn FG, Wizenberg MJ: Time-dose-volume relationship in Hodgkin’s disease. Radiology 89:919–922, 1967.

    PubMed  CAS  Google Scholar 

  50. Fischer JJ, Fischer DB: The determination of time-dose relationships from clinical data. Br J Radiol 44:785–792, 1971.

    Article  PubMed  CAS  Google Scholar 

  51. Ibrahim E, Fuller LM, Gamble JF, Jing B-S, Butler JJ, Gehan EA: Stage I Hodgkin’s disease. Comparison of surgical staging with incidence of new manifestations in lympho-gram and prelymphogram studied patients. Radiology 104:145–151, 1972.

    PubMed  CAS  Google Scholar 

  52. Million RR: The lymphomatous disease. In: Textbook of radiotherapy, Fletcher GH, ed. Philadelphia: Lea & Febiger, 1980, pp 584–636.

    Google Scholar 

  53. Fazekas JT, Cox JD, Turner WM: Irradiation of stage I and II Hodgkin’s disease. Am J Roentgenol 123:154–162, 1975.

    CAS  Google Scholar 

  54. Johnson RE, Ruhl U, Johnson SK, Glover M: Split-course radiotherapy of Hodgkin’s disease. Local tumor control and normal tissue reactions. Cancer 37:1713–1717, 1976.

    Article  PubMed  CAS  Google Scholar 

  55. Kaplan HS: Hodgkin’s disease. Cambridge, Mass.: Harvard University Press, 1980.

    Google Scholar 

  56. Hall EJ: Radiobiology for the radiologist. Hagerstown, Md: Harper & Row, 1978.

    Google Scholar 

  57. Johnson RE: Clinical and technical aspects of total nodal irradiation for Hodgkin’s disease. In: Textbook of radiotherapy, 2nd edn, Fletcher GH, ed. Philadelphia: Lea & Febiger, 1973, pp 527–544.

    Google Scholar 

  58. Johnson RE, Zimbler H, Berard CW, Herdt J, Brereton HD: Radiotherapy results for nodular sclerosing Hodgkin’s disease after clinical staging. Cancer 39:1439–1444, 1977.

    Article  PubMed  CAS  Google Scholar 

  59. Stoffel TJ, Cox JD: Hodgkin’s disease stage I and II. A comparison of two different treatment policies. Cancer 40:90–97, 1977.

    Article  PubMed  CAS  Google Scholar 

  60. Mauch P, Goodman R, Hellman S: The significance of mediastinal involvement in early stage Hodgkin’s disease. Cancer 42:1039–1045, 1978.

    Article  PubMed  CAS  Google Scholar 

  61. van der Werf-Messing B: Morbus Hodgkin’s disease, stages I and II: trial of the European Organization for Research on Treatment of cancer. Natl Cancer Inst Monogr 36:331–386, 1973.

    Google Scholar 

  62. Mill WB, Palmer-Hanes LA, Purdy JA, Tillack TW, Reinhard EH, Loeb V, Parnell DN, Penkoske MA, Franssila KO: Extended field radiation therapy in Hodgkin’s disease. Analysis of failures. Cancer 40:2896–2904, 1977.

    Article  PubMed  CAS  Google Scholar 

  63. Levi JA, Wiernik PH, O’connell MJ: Patterns of relapse in stages I, II and IIIA Hodgkin’s disease: Influence of initial therapy and implications for the future. Int J radiat Oncol Biol Phys 2:853–862, 1977.

    Article  PubMed  CAS  Google Scholar 

  64. Mintz J, Miller JB, Golomb HM, Kinzie J, Sweet DL, Lester EP, Variakojis D, Roth NO, Blough RR, Ferguson DJ, Ultmann JE: Pathologic state I and II Hodgkin’s disease 1968-1975. Relapses and results of retreatment. Cancer 44:72–79, 1979.

    Article  PubMed  CAS  Google Scholar 

  65. Prosnitz LR, Curtis AM, Knowlton AH, Peters LM, Farber LR: Supradiaphragmatic Hodgkin’s disease: significance of large mediastinal masses. Int J Radiat Oncol Biol Phys 6:809–814, 1980.

    Article  PubMed  CAS  Google Scholar 

  66. Marks JE, Haus AG, Sutton HG, Griem ML: Localization error in the radiotherapy of Hodgkin’s disease and malignant lymphoma with extended mantle fields. Cancer 34:83–90, 1974.

    Article  PubMed  CAS  Google Scholar 

  67. Prosnitz LR, Montalvo RL, Fischer DB, Silberstein AB, Berger DS: Treatment of stage IIIA Hodgkin’s disease: is radiotherapy alone adequate? Int J Radiat Oncol Biol Phys 4:781–787, 1978.

    PubMed  CAS  Google Scholar 

  68. Carmel RJ, Kaplan HS: Mantle irradiation in Hodkin’s disease. An analysis of technique, tumor eradication, and complications. Cancer 37:2813–2825, 1976.

    Article  PubMed  CAS  Google Scholar 

  69. Thar TL, Million RR, Hasner RJ, McKetty MHB: Hodgkin’s disease, stages I and II. Ralationship of recurrence tosize of disease, radiation dose, and number of sites involved. Cancer 43:1101–1105, 1979.

    Article  PubMed  CAS  Google Scholar 

  70. Mauch P, Goodman R, Rosenthal DS, Botnick L, Piro AJ, Hellman S: An evaluation of total nodal irradiation as treatment for stage IIIA Hodgkin’s disease. Cancer 43:1255–1261, 1979.

    Article  PubMed  CAS  Google Scholar 

  71. Suit H, Lindberg R, Fletcher GH: Prognostic significance of extent of tumor regression at completion of radiation therapy. Radiology 84:1100–1107, 1975.

    Google Scholar 

  72. Prosnitz LR, Farber LR, Fischer JJ, Bertino JR, Fischer DB: Long term remissions with combined modality therapy for advanced Hodgkin’s disease. Cancer 37:2826–2833, 1976.

    Article  PubMed  CAS  Google Scholar 

  73. Bonadonna G, Zucali R, DeLena M, Valagussa P: Combined chemotherapy (MOPP or ABVD) — radiotherapy approach in advanced Hodgkin’s disease. Cancer Treat Rep 61:769–777, 1977.

    PubMed  CAS  Google Scholar 

  74. Goodman R, Mauch P, Piro A, Rosenthal D, Goldstein M, Tullis J, Hellman S: Stages IIB and IIIB Hodgkin’s disease. Results of combined modality treatment. Cancer 40:84–89, 1977.

    Article  PubMed  CAS  Google Scholar 

  75. Coltman CA, Montague E, Moon TE: Chemotherapy and total nodal radiotherapy in pathological stage IIB, IIIA and IIIB Hodgkin’s disease. In: Adjuvant therapy of cancer, Salmon SE, Jones SE, eds. Amsterdam: Elsevier North-Holland Biomedical, 1977, pp 529–536.

    Google Scholar 

  76. Mauch P, Hellman S: Supradiaphragmatic Hodgkin’s disease: is there a place for MOPP chemotherapy in patients with bulky mediastinal disease? Int J Radiat Oncol Biol Phys 6:947–950, 1980.

    Article  PubMed  CAS  Google Scholar 

  77. Fuller LM, Gamble JF, Valazquez WS, Rodgers RW, Butler JJ, North LB, Martin RG, Gehan EA, Shullenberger CC: Evaluation of the significance of prognostic factors in stage III Hodgkin’s disease treated with MOPP and radiotherapy. Cancer 45:1352–1364, 1980.

    Article  PubMed  CAS  Google Scholar 

  78. Landbert T, Svahn-Tapper G, Wintzell K: Mantle treatment of Hodgkin’s disease. Preliminary report of side effects and early results. Acta Radiol Ther Phys Biol 10:174–186, 1971.

    Google Scholar 

  79. Hellman S, Mauch P, Goodman RL, Rosenthal DS, Maloney WC: The place of radiation therapy in the treatment of Hodgkin’s disease. Cancer 42:971–978, 1978.

    Article  PubMed  CAS  Google Scholar 

  80. Marks JE, Moran EM, Griem ML, Ultmann JE: Extended mantle radiotherapy in Hodgkin’s disease and malignant lymphoma. Am J Roentgenol 121:772–788, 1974.

    CAS  Google Scholar 

  81. Page V, Gardner A, Karzmark CJ: Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. I. The mantle technique. Radiology 96:609–626, 1970.

    PubMed  CAS  Google Scholar 

  82. Page V, Gardner A, Karzmark CJ: Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. IL The inverted-Y technique. Radiology 96:619–626, 1970.

    PubMed  CAS  Google Scholar 

  83. Cundiff JH, Cunningham JR, Golden R, Lanzl LH, Meurk ML, Ovadia J, Page V, Pope RA, Sampiere VA, Saylor WL, Shalek RJ, Suntharalingham N: A method for the calculation of dose in the radiation treatment of Hodgkin’s disease. Am J Roentgenol 117:30–44, 1973.

    CAS  Google Scholar 

  84. Weisenberger TH, Juillard GJF: Upper extremity lymphangiography in the radiation therapy of lymphomas and carcinoma of the breast. Radiology 122:227–230, 1977.

    Google Scholar 

  85. Nisce LZ, Gonzales ET, D’angio GJ, Lee BJ: Hilar irradiation in early stage Hodgkin’s disease. Clin Bull 7:135–139, 1977.

    PubMed  CAS  Google Scholar 

  86. Palos B, Kaplan HS, Karzmark CJ: The use of thin lung shields to deliver limited whole-lung irradiation during mantle-field treatment of Hodgkin’s disease. Radiology 101:441–442, 1971.

    PubMed  CAS  Google Scholar 

  87. Desser RK, Golomb HM, Ultmann JE, Ferguson DJ, Moran EM, Griem ML, Vardiman J, Miller B, Oetzel N, Sweet D, Lester EP, Kinzie JJ, Blough R: Prognostic classification of Hodgkin’s disease in pathologic stage III, based on anatomic considerations. Blood 49:883–893, 1977.

    PubMed  CAS  Google Scholar 

  88. Stein RD, Golomb HM, Diggd HC, Mauch P, Hellman S, Wiernik PH, Ultmann JE, Rosenthal DS: Anatomic substages of stage IIIA Hodgkin’s disease. A collaborative study. Ann Intern Med 92:159–164, 1980.

    PubMed  CAS  Google Scholar 

  89. Gamble JF, Fuller LM, Loh KK, Martin RG, Jing B-S, Sinkovics JG, Shullenberger CC, Butler JJ: Hodgkin’s disease and the non-Hodgkin’s lymphomas. In: Cancer patient care at M.D. Anderson Hospital and Tumor Institute, Clark RL, Howe CD, eds. Chicago: Year Book Medical, 1976, pp 125–163.

    Google Scholar 

  90. Fuller LM, Madoc-Jones H, Gamble JF, Butler JJ, Sullivan MP, Fernandez CH, Gehan EA: New assessment of the prognostic significance of histopathology in Hodgkin’s disease for laparotomy — negative I and stage II patients. Cancer 39:2174–2182, 1977.

    Article  PubMed  CAS  Google Scholar 

  91. Portlock CS, Rosenberg SA, Glatstein E, Kaplan HS: Impact of salvage treatment on initial relapses in patients with Hodgkin’s disease, stage I-III. Blood 51:825–833, 1978.

    PubMed  CAS  Google Scholar 

  92. Weiler SA, Glatstein E, Kaplan HS, Rosenberg SA: Initial relapses in previously treated Hodgkin’s disease. I. Results of second treatment. Cancer 37:2840–2846, 1976.

    Article  Google Scholar 

  93. Tubiana M, van der Werf-Messing B, Langier A, Hayat M, Henry-Amar M, Attie E, Leroy T: Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin’s disease. Natl Cancer Inst Monogr 36:513–530, 1973.

    PubMed  CAS  Google Scholar 

  94. Collaborative Study: Survival and complications of radiotherapy following involved and’ extended field therapy of Hodgkin’s disease, stages I and II. Cancer 38:288–305, 1976.

    Article  Google Scholar 

  95. Chan WC, Tan CTC, Martinez A, Exelby PR, Teft M, Middleman P, D’angio GJ: Involved field radiation therapy for early stage Hodgkin’s disease in children. Preliminary results. Cancer 37:1625–1632, 1976.

    Article  Google Scholar 

  96. Miller JB, Moran EM, Desser RK, Griem ML, Ultmann JE: Results of involved field and extended field radiotherapy in patients with pathologic stage I and II Hodgkin’s disease. Am J Roentgenol 127:833–839, 1976.

    CAS  Google Scholar 

  97. Peters V: The need for a new clinical classification in Hodgkin’s disease. Cancer Res 31:1713–1722, 1971.

    PubMed  CAS  Google Scholar 

  98. Ultmann JE, DeVita VT: Hodgkin’s disease and other lymphomas. In: Harrison’s principles of internal medicine, Isselbcher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JE, eds. New York: McGraw-hill, 1980, pp 1633–1647.

    Google Scholar 

  99. Fuller LM, Gamble JF, Shullenberger CC, Butler JJ, Gehan EA: Prognostic factors in localized Hodgkin’s disease treated with regional radiation. Radiology 98:641–654, 1971.

    PubMed  CAS  Google Scholar 

  100. Tiber C, Conrad F, Gehan E: Laparotomy in stage I Hodgkin’s. Proc Am Soc Clin Oncol 21:467, 1980.

    Google Scholar 

  101. Krikorian JG, Portlock CS, Rosenberg SA, Kaplan HS: Hodgkin’s disease, stages I and II occurring below the diaphragm. Cancer 43:1866–1871, 1979.

    Article  PubMed  CAS  Google Scholar 

  102. Kaplan HS: Hodgkin’s disease: unfolding concepts concerning its nature, management and prognosis. Cancer 45:2439–2474, 1980.

    Article  PubMed  CAS  Google Scholar 

  103. Smithers DW: Spread of Hodgkin’s disease. Lancet 1:1262–1267, 1970.

    Article  PubMed  CAS  Google Scholar 

  104. Hoppe RT: Radiation therapy in the treatment of Hodgkin’s disease. Semin Oncol 7; 144–154, 1980.

    PubMed  CAS  Google Scholar 

  105. Goodman RL, Piro AJ, Hellman S: Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin’s disease? Cancer 37:2834–2839, 1976.

    Article  PubMed  CAS  Google Scholar 

  106. Costello P, Mauch P: Radiographic features of recurrent intrathoracic Hodgkin’s disease following radiation therapy. AJR 133:201–206, 1979.

    PubMed  CAS  Google Scholar 

  107. Fuller LM, Gamble JF, Ibrahim E, Jing B-S, Butler JJ, Shullenberger CC: Stage II Hodgkin’s disease. Significance of mediastinal and nonmediastinal presentations. Radiology 109:429–435, 1973.

    PubMed  CAS  Google Scholar 

  108. Strum SB: The natural history, histopathology, staging, and mode of spread of Hodgkin’s disease. Series Haematol 6:20–115, 1973.

    CAS  Google Scholar 

  109. Valentjas E, Barrett A, McElwain TJ, Peckham MJ: Mediastinal involvement in early-stage Hodgkin’s disease. Response to treatment and pattern of relapse. Europ J Cancer 16:1065–1068, 1980.

    Article  Google Scholar 

  110. Levi JA, Wiernik PH: Limited extranodal Hodgkin’s disease. Unfavourable prognosis and therapeutic implications. Am J Med 63:365–372, 1977.

    Article  PubMed  CAS  Google Scholar 

  111. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the committee on Hodgkin’s disease staging classification.Cancer Res 31:1860–1861, 1971.

    PubMed  CAS  Google Scholar 

  112. Ewing J: Neoplastic diseases, 4th edn. Philadelphia: W.B. Saunders, 1940.

    Google Scholar 

  113. Thomson AD: The thymic origin of Hodgkin’s disease. Br J Cancer 9:37–50, 1955.

    Article  PubMed  CAS  Google Scholar 

  114. Keller AR, Castleman B: Hodgkin’s disease of the thymus gland. Cancer 33:1615–1623, 1974.

    Article  PubMed  CAS  Google Scholar 

  115. Filly R, Blank N, Castellino RA: Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Radiology 120:277–281, 1976.

    PubMed  CAS  Google Scholar 

  116. Peckham MJ: Lung involvement. In: Hodgkin’s disease, Smithers D, ed. Edinburgh: Churchill Livingstone, 1973, pp 118–127.

    Google Scholar 

  117. Musshoff K: Prognostic and therapeutic implications of staging in extranodal Hodgkin’s disease. Cancer Res 31:1814, 1971.

    PubMed  CAS  Google Scholar 

  118. Rosenberg SA, Kaplan HS, Glatstein EJ, Portlock CS: Combined modality therapy of Hodgkin’s disease. A report on the Stanford trials. Cancer 42:991–1000, 1978.

    Article  PubMed  CAS  Google Scholar 

  119. Rosenberg SA, Kaplan HS: The management of stages I, II, and III Hodgkin’s disease with combined radiotherapy and chemotherapy. Cancer 35:55–63, 1975.

    Article  PubMed  CAS  Google Scholar 

  120. Coltman CA, Fuller LM, Fisher R, Frei E: Extended field radiotherapy versus involved field radiotherapy plus MOPP in stage I and II Hodgkin’s disease. In: Adjuvant therapy of cancer, Jones SE, Salmon SE, eds. New York: Grune & Stratton, 1979.

    Google Scholar 

  121. Castellino RA, Glatstein E, Turbow MM, Rosenberg SA, Kaplan HS: Latent radiation injury of lungs or heart activated by steroid withdrawal. Ann Intern Med 80:593–599, 1974.

    PubMed  CAS  Google Scholar 

  122. Gains RA: Complications of chemotherapy in the treatment of Hodgkin’s disease. Semin Oncol 7:184–186, 1980.

    Google Scholar 

  123. DeVita VT, Simon RM, Hubbard SM, Young RC, Berard CW, Moxley JH, Frei E, Carbone PP, Canellos GP: Curability of advanced Hodgkin’s disease with chemotherapy. Ann Intern Med 92:587–595, 1980.

    PubMed  Google Scholar 

  124. Coltman CA: Chemotherapy of advanced Hodgkin’s disease. Semin Oncol 7:155–173, 1980.

    PubMed  Google Scholar 

  125. Frei E, Luce JK, Gamble JF, Coltman CA, Constanzi JJ, Talley RW, Monto RW, Wilson HE, Hewlett JS, Delaney FC, Gehan EA: Combination chemotherapy in advanced Hodgkin’s disease. Induction and maintenance of remission. Ann Intern Med 79:376–382, 1973.

    PubMed  Google Scholar 

  126. DeVita VT, Lewis BJ, Rozencweig M, Muggia FM: The chemotherapy of Hodgkin’s disease. Past experiences and future directions. Cancer 42:979–990, 1978.

    Article  PubMed  Google Scholar 

  127. Olweny CLM, Katongole-Mbidde E, Kiire C, Lwanga SK, Magrath I, Ziegler JL: Childhood Hodgkin’s disease in Uganda. A ten year experience. Cancer 42:787–792, 1978.

    Article  PubMed  CAS  Google Scholar 

  128. Jenkin RDT, Berry MP: Hodgkin’s disease in children. Semin Oncol 7:202–211, 1980.

    PubMed  Google Scholar 

  129. Jenkin RDT, Brown TC, Peters MV, Sonley MJ: Hodgkin’s disease in children. A retrospective analysis: 1958–73. Cancer 35:979–990, 1975.

    Article  PubMed  CAS  Google Scholar 

  130. Hays DM: The staging of Hodgkin’s disease in children reviewed. Cancer 35:973–978, 1975.

    Article  PubMed  CAS  Google Scholar 

  131. Hagemeister FB, Fuller LM, North LB: Combination radiotherapy and chemotherapy in mediastinal Hodgkin’s disease. Proc Am Soc Clin Oncol 21:466, 1980.

    Google Scholar 

  132. Lee CKK, Bloomfield CD, Levitt S: Prophylactic whole lung irradiation for extensive mediastinal Hodgkin’s disease. Proc Am Soc Clin Oncol 20:441, 1979.

    Google Scholar 

  133. Piro AJ, Weiss DR, Hellman S: Mediastinal Hodgkin’s disease: a possible danger for intubation anesthesia. Int J Radiat Oncol Biol Phys 1:415–419, 1976.

    Article  PubMed  CAS  Google Scholar 

  134. British National Lymphoma Investigation: Initial treatment of stage IIIA Hodgkin’s disease. Comparison of radiotherapy with combined chemotherapy. Lancet 2:991–995, 1976.

    Google Scholar 

  135. Rosenberg SA: The management of Hodgkin’s disease. New Engl J Med 299:1246–1247, 1978.

    Article  PubMed  CAS  Google Scholar 

  136. Timothy AR, Sutcliffe SBJ, Lister TA, Wrigley PFM, Jones AE: The management of stage IIIA Hodgkin’s disease. Int J Radiat Oncol Biol Phys 6:135–142, 1980.

    Article  PubMed  CAS  Google Scholar 

  137. Hoogstraten B, Glidwell O, Holland JF, Blom J, Stutzman L, Nissen NI, Perlberg HJ, Kramer S: Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin’s disease. Cancer 43:1234–1244, 1979.

    Article  PubMed  CAS  Google Scholar 

  138. Levi JA, Wiernik PH: The therapeutic implications of splenic involvement in stage IIIA Hodgkin’s disease. Cancer 39:2158–2165, 1977.

    Article  PubMed  CAS  Google Scholar 

  139. Aisenberg AD: Current concepts in cancer. The staging and treatment of Hodgkin’s disease. New Engl J Med 299:1228–1231, 1978.

    Article  PubMed  CAS  Google Scholar 

  140. DeVita VT: The role of combined modality therapy in the treatment of stage IIIA Hodgkin’s disease. Int J Radiat Oncol Biol Phys 5:913, 1979.

    PubMed  Google Scholar 

  141. Stein RS, Hilborn RM, Flexner JM, Bolin M, Stroup S, Reynolds V, Krautz S: Anatomic substages of stage III Hodgkin’s disease. Implications for staging, therapy, and experimental design. Cancer 42:429–436, 1978.

    Article  PubMed  CAS  Google Scholar 

  142. Murthy AK, Hendrickson FR: Stage IIIA Hodgkin’s disease — a heterogeneous group? Proc Am Soc Clin Oncol 21:463, 1980.

    Google Scholar 

  143. Shipley WU, Piro AJ, Hellman S: Radiation therapy of Hodgkin’s disease: significance of splenic involvement. Cancer 34:223–229, 1974.

    Article  PubMed  CAS  Google Scholar 

  144. Shultz HP, Glatstein E, Kaplan HS: Management of presumptive or proven Hodgkin’s disease of the liver: a new radiotherapy technique. Int J Radiat Oncol Biol Phys 1:1–8, 1975.

    Article  Google Scholar 

  145. Ingold JA, Reed GB, Kaplan HS: Radiation heptatitis. Am J Roentgenol 93:200–208, 1965.

    CAS  Google Scholar 

  146. LeBourgeois JP, Meignan M, Parmentier C, Tubiana M: Renal consequences of irradiation of the spleen in lymphoma patients. Br J Radiology 52:56–60, 1979.

    Article  CAS  Google Scholar 

  147. Dailey MO, Coleman CN, Kaplan HS: Radiation-induced splenic atrophy in patients with Hodgkin’s disease and non-Hodgkin’s lymphomas. N Engl J Med 302:215–217, 1980.

    Article  PubMed  CAS  Google Scholar 

  148. Kun LE, DeVita VT, Young RC, Johnson RE: Treatment of Hodgkin’s disease using intensive chemotherapy followed by irradiation. Int J Radiat Oncol Biol Phys 1:619–626, 1976.

    Article  PubMed  CAS  Google Scholar 

  149. Hoppe RT, Portlock CS, Glatstein E, Rosenberg SA, Kaplan HS: Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin’s disease. Cancer 43:472–481, 1979.

    Article  PubMed  CAS  Google Scholar 

  150. Bergsagel D, Basco V, Bush R, Gillies J, Israels L, Whitelaw M, Miller A: Trial of MOPP alone versus MOPP and radiotherapy for advanced Hodgkin’s disease. Proc Am Soc Clin Oncol 21:464, 1980.

    Google Scholar 

  151. Young RC, Canellos GP, Chabner BA, Hubbard SM, DeVita VT: Patterns of relapse in advanced Hogkin’s disease treated with combination chemotherapy. Cancer 42:1001–1007, 1978.

    Article  PubMed  CAS  Google Scholar 

  152. Fisher RI, DeVita VT, Hubbard SP, Simon R, Young RC: Prolonged disease-free survival in Hodgkin’s disease with MOPP reinduction after first relapse. Ann InternMed 90:761–763, 1979.

    CAS  Google Scholar 

  153. Prosnitz LR, Farber LR, Fischer JJ, Bertino JR: Low-dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin’s disease. Radiology 107:187–193, 1973.

    PubMed  CAS  Google Scholar 

  154. Farber LR, Prosnitz LR, Cadman EC, Lutes R, Bertino JR, Fischer DB: Curative potential of combined modality therapy for advanced Hodgkin’s disease. Cancer 46:1509–1517, 1980.

    Article  PubMed  CAS  Google Scholar 

  155. Eastern Cooperative Oncology Group—ECOG Protocol 1476—Combined modality treatment protocol for advanced stage IIIB, IIISB and IV Hodgkin’s disease, Glick JH, Study Chairman. Ecog Operations Office 905 University Avenue, Suite 415, Madison, WI 53715.

    Google Scholar 

  156. Seydel HG, Bloedorn FG, Wizenberg MJ: Results of radiotherapeutic treatment of relapsing Hodgkin’s disease. Cancer 23:1033–1037, 1969.

    Article  PubMed  CAS  Google Scholar 

  157. Rybak ME, Weichselbaum R, Rosenthal D, Hellman S: The influence of initial pathological stage on the survival of patients who develop relapse from Hodgkin’s disease. Proc Am Soc Clin Oncol 21:470, 1980.

    Google Scholar 

  158. Timothy AR, Sutcliffe SBJ, Wrigley PFM: Hodgkin’s disease: combination chemotherapy for relapse following radical radiotherapy. Int J Radiat Oncol Biol Phys 5:165–169, 1979.

    PubMed  CAS  Google Scholar 

  159. Sullivan MP, Fuller LM, Butler JJ: Hodgkin’s disease in children. In: Clinical pediatric oncology, Sutow WW, Vietti TJ, Fernbach DJ, eds. St Louis: CV Mosby, 1977, pp 408–443.

    Google Scholar 

  160. Parker BR, Castellino RA, Kaplan HS: Pediatric Hodgkin’s disease. I. Radiographic evaluation. Cancer 37:2430–2435, 1976.

    Article  PubMed  CAS  Google Scholar 

  161. Smith IE, Peckham MJ, McElwain TJ, Gazet JC, Ausin DE: Hodgkin’s disease in children. Br J Cancer 36:120–129, 1977.

    Article  PubMed  CAS  Google Scholar 

  162. Botnick LE, Goodman R, Jaffe N, Filler R, Cassady JR: Stages I-III Hodgkin’s disease in children. Results of staging and treatment. Cancer 39:599–603, 1977.

    Article  PubMed  CAS  Google Scholar 

  163. Fuller LM, Sullivan MP, Butler JJ: Results of regional radiotherapy in localized Hodgkin’s disease in children. Cancer 32:640–645, 1973.

    Article  PubMed  CAS  Google Scholar 

  164. Dearth JC, Gilchrist GS, Bergert EO: Management of stage I, II and III Hodgkin’s disease in children. Proc Am Soc Clin Oncol 19:391, 1978.

    Google Scholar 

  165. Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS: Pediatric Hodgkin’s disease. II. Results of therapy. Cancer 37:2436–2447, 1976.

    Article  PubMed  CAS  Google Scholar 

  166. Probert JC, Parker BR, Kaplan HS: Growth retardation in children after megavoltage irradiation of the spine. Cancer 32:634–639, 1973.

    Article  PubMed  CAS  Google Scholar 

  167. Armata J, Stopyrowa J, Depowski M, Strzesynski J, Borkowski W, Kaezor Z, Depowska T: MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin’s disease in children. Acta Paediatr Scand 67:269–273, 1978.

    Article  PubMed  CAS  Google Scholar 

  168. Jenkin D, Freedman M, McClure P, Peters V, Saunders F, Sonley M: Hodgkin’s disease in children: treatment with low-dose radiation and MOPP without staging laparotomy. A preliminary report. cancer 44:80–86, 1979.

    CAS  Google Scholar 

  169. Thar TL, Million RR: Complications of radiation treatment of Hodgkin’s disease. Semin Oncol 7:174–183, 1980.

    PubMed  CAS  Google Scholar 

  170. Kim YH, Fayos JV, Sissen JC: Thyroid function following neck irradiation for malignant lymphoma. Radiology 134:205–208, 1980.

    PubMed  CAS  Google Scholar 

  171. Nelson DF, Reddy KV, O’mara RE, Rubin P: Thyroid abnormalities following neck irradiation for Hodgkin’s disease. Cancer 42:2553–2562, 1978.

    Article  PubMed  CAS  Google Scholar 

  172. Glatstein E, McHardy-Young S, Brast N, Eltringham JR, Kriss JP: Alterations in serum thyrotrophin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol 32:833–841, 1971.

    Article  CAS  Google Scholar 

  173. Speiser B, Rubin P, Casarett G: Aspermia following lower truncal irradiation in Hodgkin’s disease. Cancer 32:692–698, 1973.

    Article  PubMed  CAS  Google Scholar 

  174. Salzman JR, Kaplan HS: Effects of splenectomy on hematological tolerance during total lymphoid radiotherapy of patients with Hodgkin’s disease. Cancer 27:471–478, 1971.

    Article  PubMed  CAS  Google Scholar 

  175. Rubin P, Scarantino CW: The bone marrow organ: the critical structure in radiation-drug interaction. Int J Radiat Oncol Biol Phys 4:3–23, 1978.

    PubMed  CAS  Google Scholar 

  176. Rubin P, Landman S, Mayer E, Keller B, Ciccio S: Bone marrow regeneration and extension after extended field irradiation in Hodgkin’s disease. Cancer 32:699–711, 1973.

    Article  PubMed  CAS  Google Scholar 

  177. Sacks EL, Goris ML, Glatstein E, Gilbert E, Kaplan HS: Bone marrow regeneration following large field radiation. Influence of volume, age, dose and time. Cancer 42:1057–1065, 1978.

    Article  PubMed  CAS  Google Scholar 

  178. Steele HA, Lillicrap SC, Clink HM, Peckham MJ: The recovery of iron uptake in erythropoietic bone marrow following large field radiotherapy. Br J Radiol 52:61–66, 1979.

    Article  Google Scholar 

  179. Gale RP: Autologous bone marrow transplantation in patients with cancer. JAMA 243:540–542, 1980.

    Article  PubMed  CAS  Google Scholar 

  180. Coleman CN, Williams CJ, Flint A, Glatstein EJ, Rosenberg SA, Kaplan HS: Hematologic neoplasia in patients treated for Hodgkin’s disease. New Engl J Med 297:1249–1252, 1977.

    Article  PubMed  CAS  Google Scholar 

  181. Brody RS, Schottenfeld D, Reid A: Multiple primary cancer risk after therapy for Hodgkin’s disease. Cancer 40:1917–1926, 1977.

    Article  PubMed  CAS  Google Scholar 

  182. Cadman EC, Capizzi RL, Bertino JR: Acute nonlymphocytic leukemia. A delayed complication of Hodgkin’s disease therapy: analysis of 109 cases. Cancer 40:1280–1296, 1977.

    Article  PubMed  CAS  Google Scholar 

  183. Foucar K, McKenna RN, Bloomfield CD, Bowers TK, Brunning RD: Therapy-related leukemia. A panmyelosis. Cancer 43:1285–1296, 1979.

    Article  PubMed  CAS  Google Scholar 

  184. Brody RS, Schottenfeld D: Multiple primary cancers in Hodgkin’s disease. Semin Oncol 7:187–201, 1980.

    PubMed  CAS  Google Scholar 

  185. Rosenberg SA, Dorfman RF, Kaplan HS: A summary of the results of a review of 405 patients with non-Hodgkin’s lymphoma at Stanford University. Br J Cancer 31(supppl II): 168–173, 1975.

    Google Scholar 

  186. Brown TC, Peters MV, Bergsagel DE, Reid J: A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Br J Cancer 31(Suppl II): 174–186, 1975.

    Google Scholar 

  187. Nathwani BN: A critical analysis of the classifications of non-Hodgkin’s lymphomas. Cancer 44:347–384, 1979.

    Article  PubMed  CAS  Google Scholar 

  188. Mathe G: Integration of modern data in W.H.O. categorization of lymphosarcomas. Its value for prognosis prediction and therapeutic adaptation to prognosis. Biomedicine 26:377–384, 1977.

    PubMed  CAS  Google Scholar 

  189. Rosenberg SA, Kaplan HS: Clinical trials in the non-Hodgkin’s lymphomata at Stanford University. Experimental design and preliminary results. Br J Cancer 31(Suppl II): 456–464, 1975.

    Google Scholar 

  190. Fuks Z, Kaplan HS: Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 108:675–684, 1973.

    PubMed  CAS  Google Scholar 

  191. Reddy S, Saxena VS, Pellettiere EV, Hendrickson FR: Early nodal and extra-nodal non-Hodgkin’s lymphomas. Cancer 40:98–104, 1977.

    Article  PubMed  CAS  Google Scholar 

  192. Glatstein E, Donaldson SS, Rosenberg SA, Kaplan HS: Combined modality therapy in malignant lymphomas. Cancer Treat Rep 61:1199–1207, 1977.

    Google Scholar 

  193. Chen MG, Prosintz LR, Gonzaler-Serva A, Fischer DB: Results of radiotherapy in control of state I and II non-Hodgkin’s lymphoma. Cancer 43:1245–1254, 1979.

    Article  PubMed  CAS  Google Scholar 

  194. Rudders RA, Kaddis M, LeLellis RA, Casey H: Nodular non-Hodgkin’s lymphoma (NHL). Factors influencing prognosis and indications for aggressive treatment. Cancer 43:1643–1651, 1979.

    Article  PubMed  CAS  Google Scholar 

  195. Schein PS, DeVita VT, Hubbard S, Chabner BA, Canellos GP, Berard C, Young RC: Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 85:417–422, 1976.

    PubMed  CAS  Google Scholar 

  196. McKelvey EM, Moon TE: Curability of non-Hodgkin’s lymphomas. Cancer Treat Rep 1:1185–1190, 1977.

    Google Scholar 

  197. Sweet DL, Golomb HM, Ultmann JE, Miller BJ, Stein RS, Lester EP, Mintz U, Bitran JD, Streuli RA, Daly K, Roth NO: Cyclophosphamide, vincristine, methotrexate with leuco-vorin rescue, and cytarabine (COMLA) combination chemotherapy for advanced diffuse histiocytic lymphoma. Ann Intern Med 92:785–790, 1980.

    PubMed  CAS  Google Scholar 

  198. Heifetz LJ, Fuller LM, Rodgers RW, Martin RG, Butler JJ, North LB, Gamble JF, Shullenberger CC: Laparotomy findings in lymphangiogram — staged I and II non-Hodgkin’s lymphomas. Cancer 45:2778–2786, 1980.

    Article  PubMed  CAS  Google Scholar 

  199. Peters MV: The contribution of radiation therapy in the control of early lymphomas. Am J Roentgenol 90:956–967, 1960.

    Google Scholar 

  200. Newall J, Friedman M: Reticulum-cell sarcoma. Part II: Radiation dosage for each type. Radiology 94:643–647, 1970.

    PubMed  CAS  Google Scholar 

  201. Seydel HG, Bloedorn FG, Wizenberg M, Berk S: Time-dose relationships in radiation therapy of lymphosarcoma and giant follicle lymphoma. Radiology 98:411–418, 1971.

    PubMed  CAS  Google Scholar 

  202. Cox JD, Koehl RH, Turner WM, King FM: Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin’s malignant lymphoma). Radiology 112:179–185, 1974.

    PubMed  CAS  Google Scholar 

  203. Bitran JD, Kinzie J, Sweet DL, Variakojis D, Griem ML, Golomb HM, Mille JB, Oetzel N, Ultmann JE: Survival of patients with localized histiocytic lymphoma. Cancer 39:342–346, 1977.

    Article  PubMed  CAS  Google Scholar 

  204. Hoppe RT, Burke JS, Glatstein E, Kaplan HS: Non-Hodgkin’s lymphoma. Involvement of Waldeyer’s ring. Cancer 42:1096–1104, 1978.

    Article  PubMed  CAS  Google Scholar 

  205. Cox JD: Central lymphatic irradiation to low-dose for advanced nodular lymphoreticular tumors (non-Hodgkin’s lymphoma). Radiology 126:767–772, 1978.

    PubMed  CAS  Google Scholar 

  206. Fraser RW, Chism SE, Stern R, Fu KK, Buschke F: Clinical course of early extranodal non-Hodgkin’s lymphomas. Int J Radiat Oncol Biol Phys 5:177–183, 1979.

    PubMed  CAS  Google Scholar 

  207. Jones SE, Fuks Z, Kaplan HS, Rosenberg SA: Non-Hodgkin’s lymphomas. V. Results of radiotherapy. Cancer 32:682–691, 1973.

    Article  PubMed  CAS  Google Scholar 

  208. Banfi A, Bonadonna G, Ricci SB, Milani F, Molinari R, Monfardini S, Zucali R: Malignant lymphomas of Waldeyer’s ring: Natural history and survival after radiotherapy. Br Med J 3:140–143, 1972.

    Article  PubMed  CAS  Google Scholar 

  209. Hellman S, Chaffey JT, Rosenthal DS, Moloney WC, Canellos GP, Skarin AT: The place of radiation therapy in the treatment of non-Hodgkin’s lymphomas. Cancer 39:843–851, 1977.

    Article  PubMed  CAS  Google Scholar 

  210. Peckham MJ, Guay J-P, Hamlin IME, Lukes RJ: Survival in localized nodal and extranodal non-Hodgkin’s lymphomata. Br J Cancer 32(Suppl II):413–424, 1975.

    Google Scholar 

  211. Musshoff K, Schmidt-Vollmer H: Prognostic significance of primary site after radiotherapy in non-Hodgkin’s lymphomata. Br J Cancer 31(Suppl II): 425–434, 1975.

    Google Scholar 

  212. Toonkel LM, Fuller LM, Gamble JF, Butler JJ, Martin RG, Shullenberger CC: Laparotomy staged I and II non-Hodgkin’s lymphomas. Preliminary results of radiotherapy and adjunctive chemotherapy. Cancer 45:249–260, 1980.

    Article  PubMed  CAS  Google Scholar 

  213. Fuller LM: Results of large volume irradiation in the management of Hodgkin’s disease and malignant lymphomas originating in the abdomen. Radiology 87:1058–1064, 1966.

    PubMed  CAS  Google Scholar 

  214. Fuller LM, Banker FL, Butler JJ, Gamble JF, Sullivan MP: The natural history of non-Hodgkin’s lymphomata stages I and II. Br J Cancer 31(Suppl II):270–285, 1975.

    Google Scholar 

  215. Bitran JD Golomb HM, Ultmann JE, Sweet DL, Lester EP, Stein RS, Miller JB, Moran EM, Kinnealey AE, Vardiman JE, Kinzie J, Roth NO: Non-Hodgkin’s lymphoma, poorly differentiated lymphocytic and mixed cell types. Results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer 42:88–95, 1978.

    Article  PubMed  CAS  Google Scholar 

  216. Goffmet DR, Glatstein E, Fuks Z, Kaplan HS: Abdominal irradiation in non-Hodgkin’s lymphomas. Cancer 37:2797–2806, 1976.

    Article  Google Scholar 

  217. Glatstein E, Fuks Z, Goffinet DR, Kaplan HS: Non-Hodgkin’s lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment? Cancer 37:2806–2812, 1976.

    Article  PubMed  CAS  Google Scholar 

  218. Young RC, Johnson RE, Canellos GP, Chabner BA, Brereton HD, Berard CW, DeVita VT: Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combinations. Cancer Treat Rep 61:1153–11569, 1977.

    PubMed  CAS  Google Scholar 

  219. Portlock CS, Rosenberg SA: No initial therapy for stage III and IV non-Hodgkin’s lymphomas of favourable histologic types. Ann Intern Med 90:10–13, 1979.

    PubMed  CAS  Google Scholar 

  220. Johnson RE, Chretien PB, O’conor GT, DeVita VT, Thomas LB: Radiotherapeutic implications of prospective staging in non-Hodgkin’s lymphoma. Radiology 110:655–657, 1974.

    PubMed  CAS  Google Scholar 

  221. Fuks Z, Glatstein E, Kaplan HS: Patterns of presentation and relapse in the non-Hodgkin’s lymphomata. Br J Cancer 31(Suppl II): 286–297, 1975.

    Google Scholar 

  222. Levitt SH, Bloomfield CD, Lee CKK, Nesbit ME, McKenna W: Extended field radiother-apy in non-Hodgkin’s lymphoma. Radiology 118:457–459, 1976.

    PubMed  CAS  Google Scholar 

  223. Tubiana M, Pouillart P, Hayat M, Schlienger M, Gerard-Marchuat R, Schlumberger J, Brugere J, Amiel J-L, Mathe G: Results of radiotherapy in stages I and II of non-Hodgkin’s lymphoma. Br J Cancer 31(Suppl II):402–412, 1975.

    Google Scholar 

  224. Mill WB, Lee FA, Franssila KO: Radiation therapy treatment of stage I and II extranodal non-Hodgkin’s lymphoma of the head and neck. Cancer 45:653–661, 1980.

    Article  PubMed  CAS  Google Scholar 

  225. Risdall R, Hoppe RT, Warnke R: Non-Hodgkin’s lymphoma. A study of the evolution of the disease based upon 92 autopsied cases. Cancer 44:529–542, 1979.

    Article  PubMed  CAS  Google Scholar 

  226. Glatstein E: Alice in lymphoma-land. Int J Radiat Oncol Biol Phys 1:561–563, 1976.

    Article  PubMed  CAS  Google Scholar 

  227. Schein PS, Chabner BA, Canellos GP, Young RC, DeVIta VT: Non-Hodgkin’s lymphoma: Patterns of relapse from complete remission after combination chemotherapy. Cancer 35:354–357, 1975.

    Article  PubMed  CAS  Google Scholar 

  228. Manfardini S, Banfi A, Bonadona G, Rilke F, Milani F, Valagussa P, Lattuada A: Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 6:125–134, 1980.

    Article  Google Scholar 

  229. Nathwani BN, Kim H, Rappaport H: Malignant lymphoma, lymphoblastic. Cancer 38:964–983, 1976.

    Article  PubMed  CAS  Google Scholar 

  230. Herman TS, Hammond N, Jones SE, Butler JJ, Byrne GE, McKelvey EM: Involvement of the central nervous system by non-Hodgkin’s lymphoma. The Southwest Oncology Group Experience. Cancer 43:390–397, 1979.

    Article  PubMed  CAS  Google Scholar 

  231. Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF: Lymphosarcoma: a review of 1269 cases. Medicine 40:31–84, 1961.

    Article  PubMed  CAS  Google Scholar 

  232. Freeman C, Berg JW, Cutler SJ: Occurrence and prognosis of extranodal lymphomas. Cancer 29:252–260, 1972.

    Article  PubMed  CAS  Google Scholar 

  233. Newall J, Friedman M, de Narvaez F: Extra-lymph-node reticulum-cell sarcoma. Radiology 91:708–712, 1968.

    PubMed  CAS  Google Scholar 

  234. Cox JD: Prognostic factors in malignant lymphoreticular tumors of the small bowel and ileocecal region: a review of 50 case histories. Int J Radiat Oncol Biol Phys 5:185–190, 1979.

    PubMed  CAS  Google Scholar 

  235. Rosenfelt F, Rosenberg SA: Diffuse histiocytic lymphoma presenting with gastrointestinal tract lesions. The Stanford experience Cancer 45:2188–2193, 1980.

    CAS  Google Scholar 

  236. Brugere J, Schienger M, Gerard-Marchant R, Tubiana M, Pouillart P, Cactim Y: Non-Hodgkin’s malignant lymphomata of upper disgestive and respiratory tract: natural history and results of radiotherapy. Br J Cancer 31(Suppl II) 435–440, 1975.

    Google Scholar 

  237. Wang DS, Fuller LM, Butler JJ, Shullenberger CC: Extranodal non-Hodgkin’s lymphomas of the head and neck. Am J Roentgenol 123:471–481, 1975.

    Google Scholar 

  238. Wang CC: Malignant lymphoma of Waldeyer’s ring. Radiology 92:1335–1339, 1969.

    PubMed  CAS  Google Scholar 

  239. Terz JJ, Farr HN: Primary lymphosarcoma of the tonsil. Surgery 65:772–776, 1969.

    PubMed  CAS  Google Scholar 

  240. Wang CC: Primary malignant lymphoma of the oral cavity and paranasal sinuses. Radiology 100:151–153, 1971.

    PubMed  CAS  Google Scholar 

  241. Sofferman RA, Cummings CW: Malignant lymphoma of the paranasal sinuses. Arch Otolaryngol 101:287–292, 1975.

    PubMed  CAS  Google Scholar 

  242. Woolner LB, McConatrey WM, Beatirs OH, Black BM: Primary malignant lymphoma of the thyroid. A review of forty-six cases. Am J Surg 111:502–523, 1966.

    Article  PubMed  CAS  Google Scholar 

  243. Ragfield EJ, Nishiyama RH, Sisson JC: Small cell tumors of the thyroid. A clinicopatho-logic study. Cancer 28:1023–1030, 1971.

    Article  Google Scholar 

  244. Burke JS, Butler JJ, Fuller LM: Malignant lymphomas of the thyroid. A clinical pathologic study of 35 patients including ultrastructural observations. Cancer 39:1587–1602, 1977.

    Article  PubMed  CAS  Google Scholar 

  245. Williams ED: The pathology of thyroid malignancy. Br J Surg 62:757–759, 1975.

    Article  PubMed  CAS  Google Scholar 

  246. Cameron RG, Seemayer TA, Wang N-S, Ahmed MN, Tabath EJ: Small cell malignant tumors of the thyroid. A light and electron microscopic study. Human Pathology 6:731–740, 1975.

    Article  PubMed  CAS  Google Scholar 

  247. Hainan KE: The non-surgical treatment of thyroid cancer. Br J Surg 62:769–771, 1975.

    Article  Google Scholar 

  248. Kim YH, Fayos JV: Primary orbital lymphoma: a radiotherapeutic experience. Int J Radiat Oncol Biol Phys 1:1099–1105, 1976.

    Article  PubMed  CAS  Google Scholar 

  249. Isaacson P, Wright DH, Judd MA, Mepam BL: Primary gastrointestinal lymphomas. A classification of 66 cases. Cancer 43:1805–1819, 1979.

    Article  PubMed  CAS  Google Scholar 

  250. Lewin KJ, Rauchod M, Dorfman RF: Lymphomas of the gastrointestinal tract. A study of 117 cases presenting with gastrointestinal disease. Cancer 42:693–707, 1978.

    Article  PubMed  CAS  Google Scholar 

  251. Freeman HJ, Weinstein WM, Shmitka TK, Piercy JRA, Wensel RH: Primary abdominal lymphoma. Presenting manifestation of celiac sprue or complicating dermatitis herpetiformis. Am J Med 63:585–594, 1977.

    Article  PubMed  CAS  Google Scholar 

  252. Hande KR, Fisher RI, DeVita VT, Chabner BA, Young RC: Diffuse histiocytic lymphoma involving the gastrointesinal tract. Cancer 41:1984–1989, 1978.

    Article  PubMed  CAS  Google Scholar 

  253. Dawson IMP, Cornes JS, Morson BC: Primary malignant lymphoid tumors of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 49:80–89, 1961.

    Article  PubMed  CAS  Google Scholar 

  254. Nieoloff DM, Haynes LB, Wangensteeen OH: Primary lymphosarcoma of the gastrointestinal tract. Surg Gynecol Obstet 117:433–437, 1963.

    Google Scholar 

  255. Naqvi MS, Burrows L, Kark AE: Lymphoma of the gastrointestinal tract. Prognostic guides based on 162 cases. Ann Surg 170:221–231, 1969.

    Article  PubMed  CAS  Google Scholar 

  256. Loehr WJ, Miyahead Z, Zahn FD, Gray GF, Thorbjarnarson T: Primary lymphoma of the gastrointestinal tract: a review of 100 cases. Ann Surg 170:232–238, 1969.

    Article  PubMed  CAS  Google Scholar 

  257. Kahn LB, Selzer G, Kaschula ROC: Primary gastrointestinal lymphoma. A clinieopatho-logic study of fifty-seven cases. Am J Dig Dis 17:219–232, 1972.

    Article  PubMed  CAS  Google Scholar 

  258. Freund H, Lavi A, Pfeffermann R, Durst AL: Primary neoplasms of the small bowel. Am J Surg 135:757–759, 1978.

    Article  PubMed  CAS  Google Scholar 

  259. Lim FE, Hartman AS, Tan EGC, Cady B, Meissner WA: Factors in the prognosis of gastric lymphoma. Cancer 39:1715–1720, 1977.

    Article  PubMed  CAS  Google Scholar 

  260. Bush RS, Ash CL: Primary lymphoma of the gastrointestinal tract. Radiology 92:1349–1354, 1969.

    PubMed  CAS  Google Scholar 

  261. Fisher RI, DeVita VT, Johnson BL, Simon R, Young RC: Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 63:177–182, 1977.

    Article  PubMed  CAS  Google Scholar 

  262. Parker F, Jackson H: Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 68:45–53, 1939.

    Google Scholar 

  263. Francis KC, Higinbotham NL, Coley BI: Primary reticulum cell sarcoma of bone. Report of 44 cases. Surg Gynecol Obstet 99:142–146, 1954.

    Google Scholar 

  264. Donal PA: Reticulum cell sarcoma of bone. Am J Roentgenol 87:121–127, 1962.

    Google Scholar 

  265. Wang CC, Fleischli DJ: Primary reticulum cell sarcoma of bone. With emphasis on radiation therapy. Cancer 22:994–998, 1968.

    Article  PubMed  CAS  Google Scholar 

  266. Dahlin DC: Is it worthwhile to differentiate Ewing’s sarcoma and primary lymphoma of bone? Seventh National Cancer Conference Proceedings. Philadelphia: JB Lippincott, 1973, pp 941–945.

    Google Scholar 

  267. Phillips TL, Sheline GE: Radiation therapy of malignant bone tumors. Radiology 92:1537–1545, 1969.

    PubMed  CAS  Google Scholar 

  268. Miller TR, Nicholson JT: End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and/or radiotherapy (47 cases) or with concurrent infection (5 cases). Cancer 27:524–548, 1971.

    Article  PubMed  CAS  Google Scholar 

  269. Ribeiro GG: Primary lymphosarcoma and reticulum cell sarcoma of skin. A review of thirty-two cases. Clin Radiol 23:279–285, 1972.

    Article  PubMed  CAS  Google Scholar 

  270. Kim R, Winkelmann RF, Dockerty M: Reticulum cell sarcoma of the skin. Cancer 16:646–655, 1963.

    Article  PubMed  CAS  Google Scholar 

  271. Levitt JL, Dawson DM, Rosenthal DS, Moloney WC: CNS involvement in the non-Hodgkin’s lymphomas. Cancer 45:454–552, 1980.

    Article  Google Scholar 

  272. Shawnburg HH, Plank CR, Adams RD: The reticulum cell sarcoma — microglioma group of brain tumors. Brain 95:199–212, 1972.

    Article  Google Scholar 

  273. Henry JM, Heffner RR, Dillard SH, Earle KM, Dewis RL: Primary malignant lymphoma of the central nervous system. Cancer 34:1293–1302, 1974.

    Article  PubMed  CAS  Google Scholar 

  274. Littman P, Wang CC: Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer 35:1412–1420, 1975.

    Article  PubMed  CAS  Google Scholar 

  275. Sagerman RH, Cassady JR, Chang CH: Radiation therapy for intracranial lymphoma. Radiology 88:552–554, 1967.

    PubMed  CAS  Google Scholar 

  276. Klingele TG, Hogan MJ: Ocular reticulum cell sarcoma. Am J Ophthalmol 79:39–47, 1975.

    PubMed  CAS  Google Scholar 

  277. Margolis L, Fraser R, Lichter A, Char DH: The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 45:688-269, 1980.

    Google Scholar 

  278. Chorlton I, Norris HJ, King FM: Malignant reticuloendotheial disease involving the ovary as a primary manifestation. A series of 19 lymphomas and 1 granulocytic sarcoma. Cancer 34:397–407, 1974.

    Article  PubMed  CAS  Google Scholar 

  279. Paladuga RR, Bearman RM, Rappaport H: Malignant lymphoma with primary manifestation in the gonad. A clinicopathologic study of 38 patients. Cancer 45:561–571, 1980.

    Article  Google Scholar 

  280. Mostofi FK: Testicular tumors. Epidemiologic, etologic and pathologic features. Cancer 32:1186–1201, 1973.

    Article  PubMed  CAS  Google Scholar 

  281. Duncan PR, Checa F, Gowing NFC, McElwain TJ, Peckham MJ: Extranodal non-Hodgkin’s lymphoma presenting in the testicle. A clinical and pathologic study of 24 cases. Cancer 45:1578–1584, 1980.

    Article  PubMed  CAS  Google Scholar 

  282. Sussman EB, Hajdu SI, Lieberman PH, Whitmore WR: Malignant lymphoma of the testis: a clinicopathologic study of 37 cases. J Urol 118:1004–1007, 1977.

    PubMed  CAS  Google Scholar 

  283. Talerman: Primary malignant lymphoma of the testis. J Urol 118:783–786, 1977.

    PubMed  CAS  Google Scholar 

  284. Kushlan P, Coleman CN, Glatstein EJ, Rosenberg SA, Kaplan HS: Prognostic factors in stage II diffuse histiocytic lymphoma. ASCO Abstracts C-122, 1978, p 337.

    Google Scholar 

  285. Miller TP, Jones SE: Chemotherapy of localized histiocytic lymphoma. Lancet 1:358–360, 1979.

    Article  PubMed  CAS  Google Scholar 

  286. Skarin AT, Rosenthal DS, Moloney WC, Frei E: Combination chemotherapy of advanced non-Hodgkin’s lymphomas with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP). Blood 49:759–770, 1977.

    PubMed  CAS  Google Scholar 

  287. Portlock CS, Rosenberg SA, Glatstein E, Kaplan HS: Treatment of advanced non-Hodgkin’s lymphomas with favourable histiologies: Preliminary results of a prospective trial. Blood 47:474–756, 1976.

    Google Scholar 

  288. Rodriguez V, Cabarillas F, Burgess MA, McKelvey EM, Valdivesio M, Bodey GP, Freireich EJ: Combination chemotherapy (‘CHOP-Bleo’) in advanced (non-Hodgkin) malignant lymphoma. Blood 49:325–333, 1977.

    PubMed  CAS  Google Scholar 

  289. Chabner BA: Nodular non Hogkin’s lymphoma: the case for watchful waiting. Ann Int Med 90:115-117, 179.

    Google Scholar 

  290. Johnson RE: Management of generalized malignant lymphomata with’ systemic’ radiotherapy. Br J Cancer 31(Suppl II):450–455, 1975.

    Google Scholar 

  291. Johnson ER, O’conor, T, Levin D: Primary management of advanced lymphosarcoma with radiotherapy. Cancer 25:787–791, 1970.

    Article  PubMed  CAS  Google Scholar 

  292. Johnson RE, Canellos GP, Young RC, Chabner BA, DeVita VT: Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Cancer Treat Rep 62:321–325, 1978.

    PubMed  CAS  Google Scholar 

  293. Johnson RE: Evaluation of fractionated total body irradiation in patients with leukemia and disseminated lymphomas. Radiology 86:185–189, 1966.

    Google Scholar 

  294. Johnson RE: Total body irradiation (TBI) as primary therapy for advanced lymphosarco-ma. Cancer 35:242–245, 1975.

    Article  PubMed  CAS  Google Scholar 

  295. Thar TL, Million RR, Noyes WD: Total body irradiation in non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 5:171–176, 1979.

    PubMed  CAS  Google Scholar 

  296. Choi NC, Timothy AR, Kaufman SD, Carey RW, Aisenberg AC: Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin’s lymphoma. Cancer 43:1636–1642, 1979.

    Article  PubMed  CAS  Google Scholar 

  297. Chaffey JT, Rosenthal DS, Moloney WC, Hellman S: Total body irradiation as treatment for lymphosarcoma. Int J Radiat Oncol Biol Phys 1:399–405, 1976.

    Article  PubMed  CAS  Google Scholar 

  298. Caravell SC, Chaffey JT, Rosenthal DS, Moloney, WC, Hellman S: Results of total body irradiation in the treatment of advanced non-Hodgkin’s lymphomas. Cancer 43:994–1000, 1979.

    Article  Google Scholar 

  299. Herman TS, Jones SE: Systematic re-staging in the management of non-Hodgkin’s lymphomas. Cancer Treat REP 61:1009–1015, 1977.

    PubMed  CAS  Google Scholar 

  300. Eastern Cooperative Oncology Group — ECOG Protocol 4477 — Combined modality treatment protocol for stages III and IV favorable (nodular) histologic subtypes of non-Hodgkin’s lymphoma. Glick JH, Study Chairman. ECOG Operations Office, 905 University Avenue, Suite 415, Madison, WI 53715.

    Google Scholar 

  301. Elias L, Portlack CS, Rosenberg SA: Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer 42:1705–1710, 1978.

    Article  PubMed  CAS  Google Scholar 

  302. Jones SE, Grozea PN, Metz EN, Haut A, Stephens RL, Morrison FS, Butler JJ, Byrne GE, Moon TE, Fisher R, Haskins CL, Coltman CA: Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma. A Southwest Oncology Group Study. Cancer 43:417–425, 1979.

    Article  PubMed  CAS  Google Scholar 

  303. Harrison DT, Neiman PE, Sullivan K, Hafermann M, Rudolph BH, Einstein EB: Combined modality therapy for advanced diffuse lymphocytic and histiocytic lymphomas. Cancer 42:1697–1704, 1978.

    Article  PubMed  CAS  Google Scholar 

  304. Pinkel D, Johnson W, Aur RJA: Non-Hodgkin’s lymphoma in children. Br J Cancer 31(Suppl II):298–323, 1975.

    Google Scholar 

  305. Lemerle M, Gerard-Marchant R, Sancho H, Schweizguth O: Natural history of non-Hodgkin’s malignant lymphomata in children. A retrospective study of 190 cases. Br J Cancer 31(Suppl II):324–331, 1975.

    Google Scholar 

  306. Murphy SB: Management of childhood Non-Hodgkin’s lymphoma. Cancer Treat Rep 61:1161–11783, 1977.

    PubMed  CAS  Google Scholar 

  307. Wollner N, Lieberman P, Exelby P, D’angio G, Burchenl J, Fang S, Murphy ML: Non-Hodgkin’s lymphoma in children: results of treatment with LSA2-L2 protocol. Br J Cancer 31(Suppl II): 337–342, 1975.

    Google Scholar 

  308. Murphy SB: Classification staging and end results of treatment of childhood non-Hodgkin’s lymphomas: Dissimilarities from lymphomas in adults. Semin Oncol 7:332–339, 1980.

    PubMed  CAS  Google Scholar 

  309. Nelson DF, Cassady JR, Traggis D, Baez-Giangreco A, Vawater GF, Jaffe N, Filler RM: The role of radiation therapy in localized resectable intestinal non-Hodgkin’s lymphoma in children. Cancer 39:89–97, 1977.

    Article  PubMed  CAS  Google Scholar 

  310. Wollner N, Wachtel AE, Exelby PE, Centore D: Improved prognosis in children with intra-abdominal non-Hodgkin’s lymphoma following LSA2L2 protocol chemotherapy. Cancer 45:3034–3039, 1980.

    Article  PubMed  CAS  Google Scholar 

  311. Murphy SB, Hustu HO: A randomized trial of combined modality therapy of childhood non-Hodgkin’s lymphoma. Cancer 45:630–637, 1980.

    Article  PubMed  CAS  Google Scholar 

  312. Carabell SC, Cassady JR, Weinstein HJ, Jaffe N: The role of radiation therapy in the treatment of pediatric non-Hodgkin’s lymphomas. Cancer 42:2193–2205, 1978.

    Article  PubMed  CAS  Google Scholar 

  313. Jenkins RDT, Souley MJ, Stephens CA, Darte JMM, Peters MV: Primary gastrointestinal tract lymphoma in childhood. Radiology 92:763–767, 1969.

    Google Scholar 

  314. Traggis D, Jaffe N, Vawater G, Baez-Giangreco A: Non-Hodgkin’s lymphoma of the head and neck in childhood. J Pediatr 87:933–936, 1975.

    Article  PubMed  CAS  Google Scholar 

  315. Jenkin RDT: The management of malignant lymphoma in childhood. In: Modern radiotherapy-malignant disease in children, Dealey TJ, ed. London: Butterworths, 1974, pp 341–359.

    Google Scholar 

Download references

Authors
  1. Gunar Zagars
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Rochester Cancer Center, USA

    John M. Bennett

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Martinus Nijhoff Publishers, The Hague/Boston/London.

About this chapter

Cite this chapter

Zagars, G., Rubin, P. (1981). The Role of Radiation Therapy in Malignant Lymphomas, Including Hodgkin’s Disease. In: Bennett, J.M. (eds) Lymphomas 1. Cancer Treatment and Research, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8279-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8279-6_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8281-9

  • Online ISBN: 978-94-009-8279-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation